0.000
Close （ET）Quotes delayed by 15 min
--Market Cap
--P/E TTM
More Details of Procaps Group SA Company
Procaps Group SA is a Luxembourg-based healthcare and pharmaceutical company. The Company develops, manufactures and sells prescription drugs and products that are differentiated by their combinations and pharmaceutical forms, as well as nutritional supplements which include omega 3 fish oils and high-potency clinical compounds. It operates its business through 5 units which are Diabetrics, Farma Procaps, Softi Gel, Vital Care, and Clinical Specialties. Diabetrics provides diabetes solutions. Farma procaps formulates, manufactures and markets branded prescription drugs in Latin America. Softi Gel provides contract drug development and manufacturing services to third party pharmaceutical companies. Vital Care develops, manufactures and markets consumer healthcare products. Clinical Specialties develops, manufactures and markets complex drugs.
undefined Info
Ticker SymbolPROC
Company nameProcaps Group SA
IPO dateDec 09, 2019
CEOMr. Jose Antonio Vieira
Number of employees- -
Security typeOrdinary Share
Fiscal year-end- -
Address9, rue de Bitbourg
CityLUXEMBOURG
Stock exchangeLondon Stock Exchange
CountryLuxembourg
Postal code1273
Phone
Websitehttps://www.procapsgroup.com/
Ticker SymbolPROC
IPO dateDec 09, 2019
CEOMr. Jose Antonio Vieira
Company Executives of undefined
Name
Name/Position
Position
Shareholding
Change
Mr. Nicolas Francisco Weinstein Manieu
Mr. Nicolas Francisco Weinstein Manieu
Director
Director
--
--
Ms. Grethel Moreno Romero
Ms. Grethel Moreno Romero
Vice President - Audit and Internal Controls
Vice President - Audit and Internal Controls
--
--
Mr. Jose Minski
Mr. Jose Minski
Director
Director
--
--
Mr. Luis Alberto Palacios Aragon
Mr. Luis Alberto Palacios Aragon
Vice President - International Marketing and R&D
Vice President - International Marketing and R&D
--
--
Mr. Jose Guillermo Frugone Domke
Mr. Jose Guillermo Frugone Domke
Director
Director
--
--
Mr. Jose Antonio Vieira
Mr. Jose Antonio Vieira
Chief Executive Officer
Chief Executive Officer
--
--
Mr. Alejandro Kostia Nicolas Weinstein Crenovich
Mr. Alejandro Kostia Nicolas Weinstein Crenovich
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Mr. Ernesto Carrizosa
Mr. Ernesto Carrizosa
Director
Director
--
--
Ms. Melissa Angelini
Ms. Melissa Angelini
Interim Vice President - Finance
Interim Vice President - Finance
--
--
Mr. Mauricio Castaneda Caballero
Mr. Mauricio Castaneda Caballero
Vice President - Human Resources
Vice President - Human Resources
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Nicolas Francisco Weinstein Manieu
Mr. Nicolas Francisco Weinstein Manieu
Director
Director
--
--
Ms. Grethel Moreno Romero
Ms. Grethel Moreno Romero
Vice President - Audit and Internal Controls
Vice President - Audit and Internal Controls
--
--
Mr. Jose Minski
Mr. Jose Minski
Director
Director
--
--
Mr. Luis Alberto Palacios Aragon
Mr. Luis Alberto Palacios Aragon
Vice President - International Marketing and R&D
Vice President - International Marketing and R&D
--
--
Mr. Jose Guillermo Frugone Domke
Mr. Jose Guillermo Frugone Domke
Director
Director
--
--
Mr. Jose Antonio Vieira
Mr. Jose Antonio Vieira
Chief Executive Officer
Chief Executive Officer
--
--
Revenue Breakdown
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Thu, Oct 2
Updated: Thu, Oct 2
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Hoche Partners Pharma Holding, S.A.
27.19%
Flying Fish Ventures L.P
19.74%
Chemo Project SA
13.25%
Becaril SA
13.25%
Saint Thomas Commercial SA
6.94%
Other
19.62%
Shareholders
Shareholders
Proportion
Hoche Partners Pharma Holding, S.A.
27.19%
Flying Fish Ventures L.P
19.74%
Chemo Project SA
13.25%
Becaril SA
13.25%
Saint Thomas Commercial SA
6.94%
Other
19.62%
Shareholder Types
Shareholders
Proportion
Corporation
83.30%
Pension Fund
0.12%
Other
16.58%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
19
2.77M
0.12%
-697.52K
2025Q2
27
1.92B
83.42%
+1.84B
2025Q1
24
86.00M
73.90%
-595.80K
2024Q4
28
97.03M
86.00%
-747.89K
2024Q3
27
96.98M
85.95%
-803.18K
2024Q2
32
97.00M
85.98%
-1.12M
2024Q1
34
96.91M
85.90%
-1.51M
2023Q4
37
97.07M
86.03%
-1.58M
2023Q3
44
97.19M
86.14%
-3.51M
2023Q2
72
97.94M
86.81%
-11.80M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Hoche Partners Pharma Holding, S.A.
626.50M
27.19%
+610.62M
+3845.80%
Apr 16, 2025
Flying Fish Ventures L.P
454.88M
19.74%
+454.88M
--
Apr 09, 2025
Chemo Project SA
305.31M
13.25%
+305.31M
--
Apr 09, 2025
Becaril SA
305.31M
13.25%
+305.31M
--
Apr 09, 2025
Saint Thomas Commercial SA
159.82M
6.94%
+159.82M
--
Apr 09, 2025
Sognatore Trust
31.34M
1.36%
--
--
Apr 16, 2025
Deseja Trust
17.96M
0.78%
--
--
Apr 16, 2025
Simphony Trust
17.96M
0.78%
--
--
Apr 16, 2025
A.F.P. Habitat S.A.
2.77M
0.12%
--
--
Feb 28, 2025
View more
Related ETFs
Updated: 23 hours ago
Updated: 23 hours ago
Name
Proportion
SPDR Portfolio Emerging Markets ETF
0%
SPDR Portfolio Emerging Markets ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of --?
The top five shareholders of -- are:
Hoche Partners Pharma Holding, S.A. holds 626.50M shares, accounting for 27.19% of the total shares.
Flying Fish Ventures L.P holds 454.88M shares, accounting for 19.74% of the total shares.
Chemo Project SA holds 305.31M shares, accounting for 13.25% of the total shares.
Becaril SA holds 305.31M shares, accounting for 13.25% of the total shares.
Saint Thomas Commercial SA holds 159.82M shares, accounting for 6.94% of the total shares.
Hoche Partners Pharma Holding, S.A. holds 626.50M shares, accounting for 27.19% of the total shares.
Flying Fish Ventures L.P holds 454.88M shares, accounting for 19.74% of the total shares.
Chemo Project SA holds 305.31M shares, accounting for 13.25% of the total shares.
Becaril SA holds 305.31M shares, accounting for 13.25% of the total shares.
Saint Thomas Commercial SA holds 159.82M shares, accounting for 6.94% of the total shares.
What are the top three shareholder types of --?
The top three shareholder types of -- are:
Hoche Partners Pharma Holding, S.A.
Flying Fish Ventures L.P
Chemo Project SA
Hoche Partners Pharma Holding, S.A.
Flying Fish Ventures L.P
Chemo Project SA
How many institutions hold shares of -- (--)?
As of 2025Q3, 19 institutions hold shares of --, with a combined market value of approximately 2.77M, accounting for 0.12% of the total shares. Compared to 2025Q2, institutional shareholding has increased by -83.30%.
What is the biggest source of revenue for --?
In --, the -- business generated the highest revenue for --, amounting to -- and accounting for --% of total revenue.
